DUBLIN--(BUSINESS WIRE)-- <\/p>\n
Research and Markets (http:\/\/www.researchandmarkets.com\/research\/55snsq\/global_plaque<\/a>) has announced the addition of the \"Global Plaque Psoriasis Pipeline Capsule - 2013\" report to their offering. <\/p>\n Fore Pharma's latest report Global Plaque Psoriasis Pipeline Capsule - 2013' provides up-to-date information on key Research and Development (R&D) activities in the global plaque psoriasis market. It covers active plaque psoriasis pipeline molecules in clinical trials, preclinical research, and drug discovery. <\/p>\n This report helps executives track competitor pipeline molecules. The pipeline data presented in this report can be used for identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals. <\/p>\n The scope of the report includes information on plaque psoriasis pipeline molecules by clinical trial stages, company, mechanism of action, and country (The US, Germany, France, Italy, Spain, UK, Japan, and Rest of the World). Plaque psoriasis pipeline molecules licensing activities are also covered in this report. <\/p>\n Key Topics Covered <\/p>\n 1. Plaque Psoriasis - Disease Overview <\/p>\n 2. Plaque Psoriasis Pipeline Overview <\/p>\n 3. Plaque Psoriasis Pipeline by Geography <\/p>\n 4. Plaque Psoriasis Phase 3 Clinical Trial Pipeline Insights <\/p>\n <\/p>\n Continued here:<\/p>\n Research and Markets: Global Plaque Psoriasis Pipeline Capsule - 2013<\/a><\/p>\n","protected":false},"excerpt":{"rendered":" DUBLIN--(BUSINESS WIRE)-- Research and Markets (http:\/\/www.researchandmarkets.com\/research\/55snsq\/global_plaque<\/a>) has announced the addition of the \"Global Plaque Psoriasis Pipeline Capsule - 2013\" report to their offering. Fore Pharma's latest report Global Plaque Psoriasis Pipeline Capsule - 2013' provides up-to-date information on key Research and Development (R&D) activities in the global plaque psoriasis market. It covers active plaque psoriasis pipeline molecules in clinical trials, preclinical research, and drug discovery. This report helps executives track competitor pipeline molecules. The pipeline data presented in this report can be used for identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals. The scope of the report includes information on plaque psoriasis pipeline molecules by clinical trial stages, company, mechanism of action, and country (The US, Germany, France, Italy, Spain, UK, Japan, and Rest of the World). Plaque psoriasis pipeline molecules licensing activities are also covered in this report. Key Topics Covered 1. Plaque Psoriasis - Disease Overview 2. Plaque Psoriasis Pipeline Overview 3. Plaque Psoriasis Pipeline by Geography 4. Plaque Psoriasis Phase 3 Clinical Trial Pipeline Insights Continue reading